Please login to the form below

Not currently logged in
Email:
Password:

Datateam expands its med comms presence

Acquires PMLiVE publisher PMGroup

Datateam Media and Communications has purchased PMLiVE publisher PMGroup, broadening a medical communications footprint that includes Newmarket and London-based agency Hayward Medical Communications.

The two companies will continue to trade independently and PMGroup's existing leadership team of commercial director Clare Bates, editorial director Dominic Tyer, digital director Karl Equi and production director Keith Shilson will continue to manage PMGroup on a day-to-day basis.

Datateam group managing director Parvez Kayani said: “I am delighted to add PMGroup to our media and communications business and look forward to working with management at PMGroup and Hayward to take our work in this area to a new, improved level.”

In addition to PMLiVE the PMGroup's print portfolio includes PME, Communiqué and The Directory of Advertising, Branding, Creative and Digital Agencies in Healthcare.

The company's awards and events business boasts the Communiqué Awards and the Pharmaceutical Market Excellence Awards (PMEA), recognising best practice in the pharma and healthcare sectors.

PMGroup also runs the Quality in Care Programme, recognising, rewarding and sharing good practice and collaboration between the NHS, patient groups and the industry in therapy areas such as diabetes and oncology.

PMGroup chairman Mark Savage said: “After building this business for the last 25 years or so, I am pleased to see PMGroup become part of the Datateam group and I look forward to helping to integrate it into the group and seeing it flourish.”

Both Mark Savage and his wife Trish Savage, who served as PMGroup's marketing director, will continue to work with the company in a consultancy capacity during the transitional period.

19th December 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics